Florica Therapeutics, Inc. Awarded Competitive Grant from the National Science Foundation to Study Brain-Immune Axis in COVID-19

Dr. Christine Ichim, CEO of Florica Therapeutics, Inc. at her lab located at MBC Biolabs in San Francisco. Photo credit Forty-Tree Foto.